These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24655709)

  • 21. Minimally Invasive CABG or Hybrid Coronary Revascularization for Multivessel Coronary Diseases: Which Is Best? A Systematic Review and Metaanalysis.
    Guan Z; Zhang Z; Gu K; Wang H; Lin J; Zhou W; Wan F
    Heart Surg Forum; 2019 Dec; 22(6):E493-E502. PubMed ID: 31895036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year clinical and angiographic results of hybrid coronary revascularization.
    Modrau IS; Holm NR; Mæng M; Bøtker HE; Christiansen EH; Kristensen SD; Lassen JF; Thuesen L; Nielsen PH;
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1181-6. PubMed ID: 26432721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid Coronary Revascularization Versus Conventional Coronary Artery Bypass Surgery: Utilization and Comparative Outcomes.
    Hannan EL; Wu Y; Cozzens K; Sundt TM; Girardi L; Chikwe J; Wechsler A; Smith CR; Gold JP; Lahey SJ; Jordan D
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009386. PubMed ID: 33040581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and angiographic results after hybrid coronary revascularization.
    Halkos ME; Walker PF; Vassiliades TA; Douglas JS; Devireddy C; Guyton RA; Finn AV; Rab ST; Puskas JD; Liberman HA
    Ann Thorac Surg; 2014 Feb; 97(2):484-90. PubMed ID: 24140212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS).
    Ganyukov V; Kochergin N; Shilov A; Tarasov R; Skupien J; Szot W; Kokov A; Popov V; Kozyrin K; Barbarash O; Barbarash L; Musialek P
    J Interv Cardiol; 2020; 2020():5458064. PubMed ID: 31969796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.
    Kinnaird T; Kwok CS; Narain A; Butler R; Ossei-Gerning N; Ludman P; Moat N; Anderson R; Mamas MA
    Am J Cardiol; 2016 Oct; 118(8):1171-1177. PubMed ID: 27553097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Nagraj S; Tzoumas A; Kakargias F; Giannopoulos S; Ntoumaziou A; Kokkinidis DG; Alvarez Villela M; Latib A
    Catheter Cardiovasc Interv; 2022 Dec; 100(7):1182-1194. PubMed ID: 36335643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
    Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival in triple-vessel disease: Hybrid coronary revascularization compared to contemporary revascularization methods.
    Basman C; Hemli JM; Kim MC; Seetharam K; Brinster DR; Pirelli L; Kliger CA; Scheinerman SJ; Singh VP; Patel NC
    J Card Surg; 2020 Oct; 35(10):2710-2718. PubMed ID: 32725629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midterm results of coronary artery bypass graft surgery after synchronous or staged carotid revascularization.
    Xiang B; Luo X; Yang Y; Qiu J; Zhang J; Li L; Yu P; Wang W; Zheng Z
    J Vasc Surg; 2019 Dec; 70(6):1942-1949. PubMed ID: 31153704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid revascularization for multivessel coronary artery disease.
    Gąsior M; Zembala MO; Tajstra M; Filipiak K; Gierlotka M; Hrapkowicz T; Hawranek M; Poloński L; Zembala M;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1277-83. PubMed ID: 25459040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting.
    Li Y; Zhang Z; Gao J; Li C; Li K; Su P; Wang L
    Int Heart J; 2022; 63(3):441-446. PubMed ID: 35650145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization].
    Yu X; Lyu S; He J; Gao Y; Luo Y; Song X; Yuan F; Huang F; Gu C; Chen F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 May; 43(5):399-403. PubMed ID: 26419983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease: A Systematic Review and Network Meta-Analysis.
    Fan MK; Su YM; Cai XX; Gu ZS; Geng HH; Pan HY; Zhu JH; Pan M
    Medicine (Baltimore); 2015 Oct; 94(42):e1745. PubMed ID: 26496289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
    Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
    Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Qian C; Feng H; Cao J; Wei B; Wang Y
    Am J Cardiol; 2017 May; 119(9):1338-1343. PubMed ID: 28267960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrid Coronary Revascularization - Current State of the Art.
    Leyvi G; Dabas A; Leff JD
    J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3437-3445. PubMed ID: 31570244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting.
    Yu X; He J; Luo Y; Yuan F; Song X; Gao Y; Li Q; Huang F; Gu C; Lv S; Chen F
    Int Heart J; 2015; 56(1):43-8. PubMed ID: 25742942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.